BackBioGend Therapeutics , Ltd. Overview
BioGend Therapeutics Co., Ltd.

BioGend Therapeutics , Ltd. PEG Ratio

Latest PEG ratio for BioGend Therapeutics , Ltd.: -14.02 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-14.02

PEG Ratio

-14.02

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

BioGend Therapeutics , Ltd. (6733.TWO) FAQ

The latest PEG ratio for 6733.TWO is -14.02. That is below the Healthcare sector average of -6.46. Investors often review this figure alongside BioGend Therapeutics , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, 6733.TWO currently prints -14.02 for PEG ratio, while the sector average sits near -6.46. That is roughly 116.9% below the sector mean. Large gaps often invite a closer look at BioGend Therapeutics , Ltd.'s growth, margins, and balance sheet.

A PEG ratio of -14.02 for BioGend Therapeutics , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (-6.46) and with 6733.TWO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting 6733.TWO's PEG ratio (-14.02), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack BioGend Therapeutics , Ltd.'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.